Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Galina Andreevna Nerodo"'
Autor:
A. P. Men'shenina, Vera P. Nikitina, M. N. Duritskiy, Olga A. Bogomolova, Galina Andreevna Nerodo, Tat'yana A. Zykova, P. A. Kruze, V. A. Sustretov
Publikováno v:
Health Care of the Russian Federation. 62:68-75
The attention to the problem of studying etiologic structure and patterns of prevalence of sexually transmitted infections is conditioned by their high morbidity, affection of population of reproductive age mainly and aftermath effecting health of pe
Autor:
Vera P. Nikitina, Ekaterina V. Verenikina, E Yu Zlatnik, A.Yu. Ardzha, Galina Andreevna Nerodo, Oksana E. Kravtsova, Inna Arnoldovna Novikova, Elena S. Bondarenko, Ekaterina I. Zolotareva
Publikováno v:
Kazanskij Medicinskij Žurnal, Vol 99, Iss 1, Pp 10-16 (2018)
Цель. Оценить результаты применения неоадъювантной химиоиммунотерапии у пациенток с неоперабельными формами рака яичников. Методы. В и
Autor:
Elena S. Bondarenko, Oksana E. Kravtsova, I A Kosenko, A.Yu. Ardzha, Galina Andreevna Nerodo, Inna Arnoldovna Novikova, Vera P. Nikitina
Publikováno v:
Kazan medical journal. 98:503-508
Aim. To study DNA flow cytometry parameters in patients with stage III-IV ovarian cancer receiving different treatments. Methods. Surgical material obtained from 93 female patients with verified stage III-IV ovarian cancer was studied. Patients were
Publikováno v:
Bulletin of Russian State Medical University. :58-67
Autor:
Oksana E. Kravtsova, Vera P. Nikitina, Ivan S. Nikitin, Galina Andreevna Nerodo, Ekaterina V. Verenikina
Publikováno v:
Medical news of the North Caucasus. 12
Autor:
Svetlana V. Belgova, Ineya I. Zekhtser, Irina V. Tselishcheva, Anastasia Nozdricheva, Viktoria Zakharchenko, Tatiana Yu. Myagkova, Svetlana V. Abakumova, Khava A. Mogushkova, Nailya Guskova, Kristina Avanesova, Ekaterina Guskova, Izabella Torpudzhyan, Oleg I. Kit, Zinaida P. Lisunova, Galina Andreevna Nerodo, Marina A. Gusareva, Ludmila Ya. Rozenko, Nadezhda Golomeeva, Ekaterina V. Verenikina
Publikováno v:
Journal of Clinical Oncology. 36:e17505-e17505
e17505Background: The purpose of the study was to determine the VEGF-A expression in patients with cervical cancer to assess its prognostic value. Methods: The study included 82 patients (23-70 yea...
Autor:
Stanislav Stanislavovich Mezentsev, Ekaterina V. Verenikina, Oleg I. Kit, Inna Arnoldovna Novikova, Oksana E. Kravtsova, Galina Andreevna Nerodo, Anna Ardzha, Vera P. Nikitina, Elena S. Bondarenko
Publikováno v:
Journal of Clinical Oncology. 35:e17041-e17041
e17041 Background: The aim of the study was to analyze chemoimmunotherapy influence on DNA cytometric parameters in patients with ovarian cancer. Methods: The study included stage IIIC-IV ovarian cancer patients divided into two groups in dependence
Autor:
Alla V. Pustovalova, Vera P. Nikitina, Ekaterina V. Verenikina, Oksana E. Kravtsova, Ivan S. Nikitin, Galina Andreevna Nerodo
Publikováno v:
Journal of Clinical Oncology. 35:e17036-e17036
e17036 Background: The purpose of the study was to analyze neoadjuvant chemotherapy (NACT) effect on parameters of monoaminergic, free radical and hydrolytic systems in tissues of malignant ovarian tumors. Methods: Activity of parameters of monoamine
Autor:
Olga A. Bogomolova, Vera P. Nikitina, Oleg I. Kit, Oksana E. Kravtsova, Tatiana A. Zykova, Galina Andreevna Nerodo, Ekaterina V. Verenikina, Victoria A. Ivanova
Publikováno v:
Journal of Clinical Oncology. 35:e17026-e17026
e17026 Background: The purpose of the study was to identify the rate of Bacteroides spp. infection in vulvar cancer tissues. Methods: FFPE samples of tumor and peritumoral area and healthy tissues of 44 patients with vulvar cancer, as well as frozen
Autor:
Galina I. Zakora, Inna Arnoldovna Novikova, Elena P. Ulianova, Galina Andreevna Nerodo, Anna Ardzha, Evgeniya M. Nepomnyashchaya
Publikováno v:
Journal of Clinical Oncology. 35:e17038-e17038
e17038 Background: The purpose of the study was to analyze morphological and immunohistochemical changes in patients with ovarian serous carcinomas under the influence of chemoimmunotherapy. Methods: The study included patients aged 52-76 years with